Actithera

Private

Cambridge, MassachusettsHealthcare & Life Scienceshttps://actithera.com/

Last Round

Series A

Jul 9, 2025

Total Funding Raised

$80.8M

Company Overview

Actithera is a biotechnology company that develops radiopharmaceutical and next-generation radioligand therapies for cancer treatment.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

radioligand therapyRLTradiopharmaceuticalsoncologyprecision medicinemedicinal chemistryFAP-targetingdrug discoverytargeted cancer therapycovalent-targetingbiotechsolid tumor treatmenttheranostics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Actithera Comps

Public and private peers based on sector, stage, and business model.

Actithera comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Actithera Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Jul 9, 2025
Seed	Jul 1, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Andreas Goutopoulos

CEO and Founder

Founding Team

Dimitrios Mantzilas

Chief Technology Officer And Site Head For Actithera Oslo

Executive Team

Actithera Investors

Notable investors and investment history

Actithera investors
Investor	Rounds
Surveyor Capital	Series A
Innovestor	Series A
M Ventures	Seed, Series A
4Bio Capital	Series A
Investinor	Series A
Bioqube Ventures	Series A
Citadel	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Dec 3, 2025
Darshan Dalal appointed as new Chief Medical Officer.
Jul 9, 2025
$76M round completed

View all signals

Actithera Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Actithera Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Actithera's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts

Employee Range33

Year Founded2021

Last FundingJul 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.